Rational design of a small- molecule inhibitor targeting the allosteric site of sos1 in oncogenic k-ras pancreatic cancer

被引：0
|
作者：
Duan, Xin
Evelyn, Chris R.
Biesiada, Jacek
Johnson, James F.
Seibel, William L.
Meller, Jaroslaw
Zheng, Yi
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5912
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5912
引用
收藏
页数：2
相关论文
共 15 条
  • [1] Rational Design of Small Molecule Inhibitors Targeting the Ras GEF, SOS1
    Evelyn, Chris R.
    Duan, Xin
    Biesiada, Jacek
    Seibel, William L.
    Meller, Jaroslaw
    Zheng, Yi
    CHEMISTRY & BIOLOGY, 2014, 21 (12): : 1618 - 1628
  • [2] Rational design of small molecules targeting the Ras GEF, SOS1
    Evelyn, Chris
    Duan, Xin
    Biesiada, Jacek
    Seibel, William
    Meller, Jaroslaw
    Zheng, Yi
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Therapeutic Targeting of Oncogenic K-Ras by a Covalent Catalytic Site Inhibitor
    Lim, Sang Min
    Westover, Kenneth D.
    Ficarro, Scott B.
    Harrison, Rane A.
    Choi, Hwan Geun
    Pacold, Michael E.
    Carrasco, Martin
    Hunter, John
    Kim, Nam Doo
    Xie, Ting
    Sim, Taebo
    Jaenne, Pasi A.
    Meyerson, Matthew
    Marto, Jarrod A.
    Engen, John R.
    Gray, Nathanael S.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2014, 53 (01) : 199 - 204
  • [4] Novel small molecule PAK4 allosteric modulators show potency against oncogenic K-Ras driven pancreatic cancer
    Azmi, Asfar S.
    Senapedis, William T.
    Landesman, Yosef
    Baloglu, Erkan
    Bao, Bin
    Wu, Jack
    Ori, Kalid
    Shacham, Sharon
    Kauffman, Michael
    Mohammad, Ramzi M.
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [5] A New Dawn for Targeted Cancer Therapy: Small Molecule Covalent Binding Inhibitor Targeting K-Ras (G12C)
    Li, Na
    Liu, Chen-Fu
    Zhang, Wen
    Rao, Guo-Wu
    CURRENT MEDICINAL CHEMISTRY, 2025, 32 (04) : 647 - 677
  • [6] A discovery of a small molecule mTORC1 allosteric inhibitor targeting cancer cells
    Shams, Raef
    Ito, Yoshihiro
    Miyatake, Hideyuki
    CANCER RESEARCH, 2020, 80 (16)
  • [7] The survival kinase Mirk/Dyrk1B is a downstream effector of oncogenic K-ras in pancreatic cancer
    Jin, Kideok
    Park, Sunju
    Ewton, Daina Z.
    Friedman, Eileen
    CANCER RESEARCH, 2007, 67 (15) : 7247 - 7255
  • [8] Preventive Treatment with a CD73 Small Molecule Inhibitor Enhances Immune Surveillance in K-Ras Mutant Pancreatic Intraepithelial Neoplasia
    Strickland, Lincoln N.
    Liu, Wendao
    Hussein, Usama
    Mardik, Nicolette
    Chen, Xian
    Mills, Tingting
    Vornik, Lana A.
    Savage, Michelle I.
    Sei, Shizuko
    Clifford, John
    Eltzschig, Holger K.
    Brown, Powel H.
    Zhao, Zhongming
    McAllister, Florencia
    Bailey-Lundberg, Jennifer M.
    CANCER PREVENTION RESEARCH, 2024, 17 (10) : 457 - 470
  • [9] Rational combination of MEK inhibitor and the STAT3 pathway modulator for the therapy in K-Ras mutated pancreatic and colon cancer cells
    Zhao, Chengguang
    Xiao, Hui
    Wu, Xiaojuan
    Li, Chenglong
    Liang, Guang
    Yang, Shulin
    Lin, Jiayuh
    ONCOTARGET, 2015, 6 (16) : 14472 - 14487
  • [10] Targeting a cryptic allosteric site of SIRT6 with small-molecule inhibitors that inhibit the migration of pancreatic cancer cells
    Zhang, Qiufen
    Chen, Yingyi
    Ni, Duan
    Huang, Zhimin
    Wei, Jiacheng
    Feng, Li
    Su, Jun-Cheng
    Wei, Yingqing
    Ning, Shaobo
    Yang, Xiuyan
    Zhao, Mingzhu
    Qiu, Yuran
    Song, Kun
    Yu, Zhengtian
    Xu, Jianrong
    Li, Xinyi
    Lin, Houwen
    Lu, Shaoyong
    Zhang, Jian
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (02) : 876 - 889
12